-Hemophagocytic syndrome associated with strongyloidiasis in a child treated for acute lymphoblastic leukemia.
D000969:Antinematodal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D015616:Histiocytosis, Non-Langerhans-Cell / Q000209:etiology*; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000150:complications* / Q000188:drug therapy; D008463:Mebendazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D013322:Strongyloidiasis / Q000150:complications* / Q000188:drug therapy